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Atrial natriuretic factor (ANF) and C-type natriuretic peptide (CNP)-activated guanylate cyclases are single-chain transmembrane-spanning 
proteins, containing both ligand binding and catalytic activities. In both proteins, ligand binding to the extracellular receptor domain activates the 
cytosolic catalytic domain, generating the second messenger cyclic GMP. Obligatory in this activation process is an ATP-dependent step. ATP 
directly binds to a deBned ATP-regulatory module (ARM) sequence motif in the cyclases and through ARM bridges the events of ligand binding 
and signal transduction. These ARM sequence motifs are respectively represented by GlySo’-Xa-Gl$05-Xa-Xa-Xa-Gly509 and Gly@-Xa-Xa-Xa- 
Gly”’ in the case of ANF receptor guanylate cyclase (ANF-RGC) and CNP receptor guanylate cyclase (CNP-RGC). Through genetic remodeling 
techniques, we now show that ARM-GlJo5 in ANF-RGC and the corresponding ARM-Gly”% in CNP-RGC are critical for ANF and CNP 
signaling, and other ARM-Gly residues have minimal effect in the respective signaling processes. 
Guanylate cyclase; ATP-regulatory module; Atrial natriuretic factor receptor; Type C natriuretic peptide receptor 
1. INTRODUCTION 
Atria1 natriuretic factor (ANF) and brain natriuretic 
peptide (BNP) are the two members of the family of 
structurally related natriuretic peptides that regulate 
hemodynamics of the physiological processes of diu- 
resis, water balance and blood pressure (Cl]; reviewed in 
[24]). The third known member of this family is C-type 
natriuretic peptide (CNP), which in contrast to ANF 
and BNP, is far less effective in causing diuresis and 
lowering of blood pressure [5]. CNP is somewhat selec- 
tively predominant in the central nervous system [5,6], 
hence it is possible that it acts as a neurotransmitter 
and/or participates in the centrally-related fluid secre- 
tion and blood pressure regulation. One important sec- 
ond messenger of these hormones is cyclic GMP (re- 
viewed in [2-4]). The receptors for ANF (ANF-RGC) 
[7-l 31 and CNP (CNP-RGC) [ 14,151 have been charac- 
terized; both are guanylate cyclases and are structurally 
similar. Topographical models of these receptor pro- 
teins indicate similarity in that both contain a single 
membrane-spanning helical domain which divides the 
protein into two roughly equal portions, the N-terminal 
extracellular and the C-terminal intracellular; the recep- 
tor domain lies in the extracellular portion while the 
intracellular portion contains two domains, the one ad- 
jacent to the transmembrane is termed ‘kinase-like’ do- 
*Corresponding author. 
The present study addresses this issue and shows that 
a single specific Gly-ARM residue suffices as being an 
ATP switch for both ANF and CNP signaling. 
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main due to its sequence similarity to the tyrosine kinase 
family, and the C-terminal region contains the catalytic 
domain [16]. This topographical arrangement for the 
ANF-RGC protein is supported by site-directed [ 10,171 
and deletion-mutagenesis studies [16,17], in which the 
truncated-receptor cyclase showed no ANF-binding 
and ANF-dependent cyclase activities. 
Studies with ANF-RGC and CNP-RGC show that 
the mere ligand binding to the receptor domain is not 
enough to maximally stimulate the cyclase activity 
[18,19]; obligatory in this activation process is an inter- 
vening step, which is regulated by ATP [20,21]. ATP 
binding causes an allosteric change in guanylate cyclase, 
bringing it to the activated-catalytic state. A defined 
ATP-regulatory module (ARM) of ANF-RGC with a 
sequence of Gly503-Xa-Gly505-Xa-Xa-Xa-Gly509 and a 
corresponding ARM sequence of CNP-RGC, Gly4”- 
Xa-Xa-Xa-Gly503, are critical in ATP binding and am- 
plification of the hormonal signal [22]. Sequence xam- 
ination of these ARMS structural motifs reveals three 
interesting Gly-related patterns in ANF-RGC: (1) Gly- 
Xa-Gly; (2) Gly-Xa-Xa-Xa-Gly, and (3) Gly-Xa-Gly- 
Xa-Xa-Xa-Gly; and one pattern, Gly-Xa-Xa-Xa-Gly, 
in CNP-RGC, which is also shared by the ARM of 
ANF-RGC [22]. These structural features of ARM 
motifs raise a curious question regarding the role of 
individual glycine residues in the ATP-mediated event 
of ANF and CNP signal transduction processes. 
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2. MATERIALS AND METHODS identities and correct ligations. The mutated-cDNAs were individually 
The 5-kDa CNP used in these studies was a 45 amino acid peptide, 
Ser - Gln - Asp - Ser - Ala-Phe-Arg-Ile-Gln-Glu-Arg-Leu-Arg-Asn-Ser- 
Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-~g-Ile- 
Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe; and 
ANF (rat, residues 8-33) was a 26 amino acid peptide, Arg-Arg-Ser- 
Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly- 
Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr. These peptides were purchased 
from Peninsula Laboratories; GTP, cyclic GMP and bovine serum 
albumin were from Sigma; ATP was from Boehringer-Mannheim; 
[‘251]NaI was from ICN; cell culture media were from Gibco and 
restriction enzymes were purchased from USB and BioLabs. 
CNP-RGC cDNA clone was isolated from the human retina cDNA 
library [15]; ANF-RGC @Ccl-Dmut) was constructed from GCa 
cDNA [8]. ANF-RGCValSaSAsn5” was built as in [17], and ANF- 
RGCLeuS&Se~M and CNP-RGCAla499 were prepared as in [22]. 
Other mutants corresponding to the ARM sequences of ANF-RGC 
and CNP-RGC were constructed as schematically represented in 
Fig. 1 and are described below: [Ml] ANF-RGCXyp* (Tyr’“- 
minus); [M2] ANF-RGCAlaSW (GlgW-+Ala); [M3] ANF- 
RGCAlaSo’Ala5W (Gly”‘+Ala and GlySW-+41a); [M4] CNP- 
RGCAla”’ (GlySo3+Ala). 
Mutagenesis was performed on the 1.9 kb &z&XbaI fragment of 
GCa cDNA or on the 1.85 kb SalI-X&z1 fragment of CNP-RGC 
cDNA, subcloned individually into the pselect-1 vector (Promega 
mutagenesis kit). The following primers, each corresponding to the 
indicated mutant, were used: 
[Ml] 5'-GGTGGTTAGCAGGGAGCCATTGGAGCCTCGCCCACT-3' 
[M2] 5'-GGTTAGCAGGGAGGCATAATTGGAGCC-3' 
[M3] 5'-AGCCGGCTGACCCTGAGTGCGCGAGGCTCCAA-3' 
[M4] 5'-TGCGGGATCCAGTTACGCCTCGCTCATGAC-3' 
The E~~RV-XWI fragment excised from the pSelect-cDNA recom- 
binants was used to replace the EcoRV-X&I fragment of ANF-RGC 
or CNP-RGC cDNA, respectively. 
All the mutated-recombinants were sequenced [23] to confirm their 
subcloned into the XhoI-SmaI or J&I-Sac1 site of the pSVL vector 
to create pSVL-mutated cDNA expression constructs for ANF-RGC 
and CNP-RGC related mutants. 
For expression studies, COS-7 cells (simian virus 40 (SWO)-trans- 
formed African Green Monkey kidney cells) were transfected with the 
expression vector by calcium phosphate technique [24]; 60 h after 
transfection, cells were washed with 50 mM Tris-HCl (pH 7.5)/10 mM 
MgCl, buffer, scraped into 2 ml of ice-cold buffer, homogenized, 
centrifuged for 15 min at 5,000 x g and washed with the same buffer. 
The pellet represented the crude membranes. In control experiments, 
the crude membranes prepared from cells transfected with the pSVL 
vector alone were used. The crude membranes were assayed for 
guanylate cyclase activity [12]. 
3. RESULTS AND DISCUSSION 
Studies with ANF-RGC and CNP-RGC have shown 
that (1) each of these receptor cyclases contains an 
ARM sequence motif that is essential in the ATP-medi- 
ated occurrence that bridges the events of ligand bind- 
ing and signal transduction; (2) this ARM sequence 
motif is represented by Gly503-Xa-Gly505-Xa-Xa-Xa- 
Glyso9 in the case of ANF-RGC and by Xa497-Xa- 
Gly499-Xa-Xa-Xa-Gly503 in the case of CNP-RGC; (3) 
the core ARM sequence motif that is essential in both 
ANF and CNP signaling is G&-Xa-Xa-Xa-G& [22]. 
Analysis of these ARM sequence motifs reveals an in- 
triguing glycine-related pattern G&-Xa-Gly-Xa-Xa-Xa- 
G& in ANF-RGC and G&-Xa-Xa-Xa-m in CNP- 
RGC, raising a curious question regarding the individ- 
ual role of these glycine residues in the ATP-regulated 
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Fig. 1. Representation of ANF-RGC and CNP-RGC mutants. The mutated amino acid residues corresponding to the ARMS of ANF-RGC and 
CNP-RGC are indicated by shaded boxes. The appropriate changes in amino acid residues were created by site-directed mutagenesis as described 
in section 2. 
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Fig. 2. Effect of ATP and ANF on particulate guanylate cyclase activity in membranes of COS-7 cells transfected with ANF-RGC cDNA or its 
mutants. Membranes, prepared as described in section 2, were assayed for guanylate cyclase activity using MgZ’ as a cofactor in the presence of 
(A) ANF (0.1 PM) with indicated additions of ATP and (B) in the presence of 0.8 mM ATP with varied additions of ANF. The experiments were 
done in triplicate and repeated three times. Results (mean f S.D.) shown are from one typical experiment. 
event of ANF and CNP signaling. This issue was ad- which was then used to transfect COS-7 cells. The par- 
dressed by using the combined tools of genetic remodel- ticulate fractions of these cells were appropriately 
ing and site-directed mutagenesis. treated and analyzed for the cyclase activities. 
GCa is a wild type plasma membrane guanylate 
cyclase, that, with the exception of two amino acids, is 
structurally identical to ANF-RGC [8]. GCcl cyclase 
activity is independent of ANF (and other natriuretic 
peptides), and GCa is not an ANF-receptor [8]. By 
oligonucleotide-directed mutagenesis, GCa was remod- 
eled to create a mutant, GC&-Dmut, which is structur- 
ally and functionally identical to the cloned wild type 
ANF-RGC [8]. The individual glycine residues repre- 
senting ARM of the genetically-constructed ANF-RGC 
were then changed through site-directed mutagenesis to 
the other indicated residues to create the following mu- 
tants: (1) Leu503-Xa-Gly505-Xa-Xa-Xa-Gly509 [22], (2) 
Gly503-Xa-Gly505-Xa-Xa-Xa-AIa509, (3) m503-Xa-Gly- - 
Xa-Xa-Xa-AIaSW, - and (4) Gly503-Xa-m505-Xa-Xa-Xa- 
GlysW [17]. The counterpart of the ANF-RGC ARM 
structural motif in CNP-RGC is Xa497-Xa-Gly4W-Xa- 
Xa-Xa-Gly503, indicating that there is a change in the 
sequence form - there being two glycine-surrounded 
domains (Gly-Xa-Gly-Xa-Xa-Xa-m in ANF-RGC 
and only one (Gly499-Xa-Xa-Xa-GJ503) in CNP-RGC. 
To determine the role of Gly residues in CNP-RGC 
ARM sequence in CNP signaling, Gly503 and Gly4W 
residues were respectively substituted with alanine resi- 
dues at equivalent positions to create the mutated struc- 
tural motifs, Gly499-Xa-Xa-Xa-Ala503 and AIa4*-Xa- ~ 
Xa-Xa- Glyso3. The substituent resihue alanine (or val- 
ine in the case of ANF-RGC ARM) is not charged and 
is very similar to glycine in its properties, it therefore 
should cause minimal change, if any, in the tertiary 
structure of the mutated-proteins. 
Earlier studies with ANF-RGC have indicated that 
maximal guanylate cyclase activity is attained with 0.1 
,uM ANF or CNP in the presence of 800 PM ATP 
[ 10,15,21], and neither ATP nor the hormones by them- 
selves timulate the guanylate cyclase activity [10,20,21]. 
In all experiments, therefore, the ATP-dependent 
cyclase activity was assessed in the presence of the 0.1 
PM of ANF or CNP; and the hormone-dependent 
cyclase activity was measured in the presence of 800 ,uM 
ATP. These concentrations of the hormone and ATP 
are optimal in eliciting the maximal cyclase stimulation. 
The plasma membranes containing the mutated-pro- 
teins showed 30- to 50-fold higher basal activity than the 
membranes of control cells transfected with pSVL alone 
Table I 
Guanylate cyclase activity in membranes of transfected COS-7 cells 
Transfection Guanylate cyclase activity 
(pmol cyclic GMP/min/mg protein) 
pSVL (control) 
ANF-RGC 
ANF-RGCVa1505AsnS06 
ANF-RGCIeuM3Se? 
ANF-RGCAlaM9 
ANF-RGCAlaM3Asn5”s 
ANF-RGCL1 Tyrso8 
CNP-RGC 
CNP-RGCAla4W 
CNP-RGCAla”’ 
0.2 
7.1 f 1.0 
5.0 f 0.4 
8.1 f 0.5 
7.4 zt 0.6 
6.8 f 0.3 
6.6 f 0.4 
10.1 f 0.5 
11.2 f 0.6 
8.2 f 0.4 
The coding sequence of each of the mutated-proteins 
was introduced into an expression vector, pSVL, under 
the transcriptional control of the SV40 late promoter, 
COS-7 cells were transfected with appropriate ANF-RGC or CNP- 
RGC mutant cDNAs in a pSVL expression vector. Membranes were 
prepared as described in section 2, and gnanylate cyclase activity was 
determined. 
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Fig. 3. Effect of ATP and CNP on particulate guanylate cyclase activity in membranes of COS-7 cells transfected with CNP-RGC cDNA or its 
mutants. Membranes, prepared as described in section 2, were assayed for guanylate cyclase activity using Mg2f as a cofactor in the presence of 
(A) CNP (0.1 FM) with indicated additions of ATP and (B) in the presence of 0.8 mM ATP with varied additions of CNP. The experiments were 
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(Table I), in~cating that the encoded protein is a 
guanylate cyclase. 
Estimation of the role of each individual Gly residue 
comprising the ANF-RGC sequence motif Glyso3-Xa- 
GlyS05-Xa-Xa-Xa-GlySW in the ATP-mediated ANF sig- 
naling was made by comparing the results of ANF- 
RGC with those of the corresponding mutants at their 
equivalent positions. In the presence of saturating 
amo~ts of ANF (0.1 ,uM), ATP in a dose-dependent 
fashion stimulated the cyclase activity of each of the 
mutants with the sequence motifs of GlySo3-Xa-GlySo5- 
Xa-Xa-Xa-Ala5@‘, Leu503-Xa-Gly505-Xa-Xa-Xa-Gly50’ 
and Ala~3-Xa-Gly505-Xa-Xa-Xa-Ala~; the sedation 
ranged between 9- and 1 l-fold at 800 PM ATP, and the 
concentration causing half-maximal response was be- 
tween 300 to 400 ,uM (Fig. 2A). Likewise, the cyclase 
activity of these mutants in the presence of ATP was 
also stimulated by ANF in a dose-dependent manner 
(Fig. 2B); the EC,, concentration ranged between 1 and 
4 nM; an excess of threefold stimulation occurring at 
-0.1 nM ANF (Fig. 2B). These results indicate 
that the architectural integrity of the ARM sequence 
motifs - Gly503- Xa-Gly505-Xa-Xa-Xa-Gly50p, GlySo3-Xa- 
Glyso5 and Gly505-Xa-Xa-Xa-Glyso9 - as such is nones- 
sential in the ATP-mediated event of the ANF signal- 
ing; and they also reveal that similar is the case with the 
ARM-Gly residues positioned at 503 and 509. This in- 
terpretation was supported and extended by an expres- 
sion study with the ANF-RGC mutant containing the 
site-directed mutation at Gly50s. This mutant with the 
ARM structural motif of Gly503-Xa-Va1505-Xa-Xa-Xa- 
GlySop did not respond to ATP in the presence of ANF 
(0.1 PM) nor to ANF in the presence of ATP (Fig. 2; 
lJ71). 
These results establish that the architectural pattern 
of the three glycine-related motifs of the ANF-RGC 
ARM sequence is not essential in the ATP-mediated 
event of ANF signaling; most significantly, they show 
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that the most impor~t signaling component that de- 
fines the ATP switch in ARM is the single GIy505 resi- 
due. 
The counterpart of the ANF-RGC ARM-GlySo5 resi- 
due in CNP-RGC ARM is GIY~~. To determine the role 
of this residue in the ATP-mediated event of CNP sig- 
naling, the comparative expression studies were con- 
ducted with the wild type CNP-RGC and its two mu- 
tants, Gly4W-Xa-Xa-Xa-AlaS3 and Ala499-Xa-Xa-Xa- 
Glyso3. CNP-RGC cyclase activity in the presence of 
saturating amounts of CNP (0.1 ,uM) was stimulated by 
ATP in a dose-dependent fashion with an EC,o of - 400 
yM, and CNP in the presence of ATP (800 PM) caused 
the cyclase activation in a dose-dependent manner with 
an EC,, of 4 nM (Fig. 3); significant stimulation occur- 
ring below 0.1 nM CNP (Fig. 3B). A similar pattern of 
ATP and CNP stimulation of the cyclase activity was 
observed with the mutant Gly499-Xa-Xa-Xa-AlaS3, but 
in complete contrast, the ATP-dependent hormone sig- 
naling was impaired in the mutant, Ala499-Xa-Xa-Xa- 
GlySo3, indicating Gly4* is essential in CNP signaling. 
It is thus concluded that the architectural pattern of 
the glycine-related CNP-RGC ARM sequence motif, 
like ANF-RGC sequence motifs, is also not essential in 
the ATP-mediated event of CNP signaling; and again 
in parallel to the results obtained with the ANF-RGC 
ARM, the critical ATP switching component of the 
CNP-RGC ARM is the single Gly4” residue. 
A previous study has shown that the ANF-RGC 
ARM-GlySo5 and the corresponding CNP-RGC ARM- 
Gly4W residues are critical in direct ATP binding [17,22]. 
In view of the present results indicating that the same 
Gly residues constitute the critical ATP signaling com- 
ponents of the ARM residues of ANF-RGC and CNP- 
RGC, it is concluded that these residues act as direct 
ATP switches. 
These studies do not prove, however, that the ANF- 
RGC ARM-Gly residue 505 and CNP-RGC ARM-Gly 
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Fig. 4. Effect of ATP and ANF on particulate guanylate cyclase activity in membranes of COS-7 cells expressing ANF-RGC or ANF-RGCdTyr5”. 
Membranes, prepared as described in section 2, were assayed for guanylate cyclase activity using MgZ’ as a cofactor in the presence of (A) ANF 
(0.1 PM) with indicated additions of ATP and (B) in the presence of 0.8 mM ATP with various concentrations of ANF. The experiments were 
done in triplicate and repeated twice. The experiments were done in triplicate and repeated three times. Results (mean + SD.) shown are from 
one typical experiment. 
residue 499 are the direct ATP binding sites. But the 
ANF-RGC sequence motif - Gly503-Xa-GlyS05-Xa-Xa- 
Xa-GlySog - shows an interesting parallel with a con- 
served nucleotide binding sequence motif, Gly-Xa-Gly- 
Xa-Xa-Gly of protein kinases [25,26] and the GTP- 
binding protein, ~21 [27]. The ‘predicted nucleotide- 
binding protein model’ indicates that the second glycine 
in the structural motif Gly-Xa-Gly-Xa-Xa-Gly is crucial 
in the direct GTP binding to the p21 protein [27], as also 
appears to be true in the case of ANF-RGC signaling. 
But this parallel is not total, because the first Gly-re- 
lated structural motif (Gly-Xa-Gly) is absent in the 
CNP-RGC ARM motif Xa4g7-Xa-Gly4gg-Xa-Xa-Gly. In 
this case Gly4” is functionally equivalent o the middle 
glycine representing the structural motifs of ANF-RGC 
and the ~21. Similarly, there does not appear to be a 
complete parallel in reference to the structural motif 
Gly-Xa-Xa-Xa-Gly comprising the ARMS of ANF- 
RGC and CNP-RGC with those of the protein kinases 
Gly-Xa-Xa-Gly, as is evident from the results obtained 
with the ANF-RGC mutant, Gly503-Xa-Gly505-Xa-Xa- 
Gly (ANF-RGCmyr508): This mutant is responsive to 
the ATP-dependent hormone stimulation (Fig. 4). 
Thus, these structural parallels of protein kinases and 
GTP-binding proteins with those of the ATP-responsive 
membrane guanylate cyclases may merely be reflective 
of their evolutionary linkage rather than functional. In 
any event these ATP studies have started to show a 
unique regulatory signal transduction feature of the 
natriuretic factor receptor cyclases: the single ARM Gly 
residue defines the ATP switch in hormone signaling. 
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